Literature review · Muscle & strength / Metabolism & weight

GHRP-2

A small human experiment found increased food intake and GH release. Appetite stimulation in that experiment is not evidence of weight loss or muscle gain.

By HeartPep · Reviewed · 2 selected source records

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

At a glance

The selected primary study is an acute, controlled human physiology experiment. Its direct findings concern one meal and hormone measurements.

Identity & scope

GHRP-2 is a synthetic GH secretagogue used to investigate ghrelin-related physiology. The cited experiment used a defined research preparation.

Catalogue labels covered: GHRP-2.

What the research shows

  • The appetite endpoint is particularly relevant when interpreting a metabolism category: metabolism research can include greater food intake.

Critical interpretation

An acute appetite finding is more specific than a metabolism claim

The seven-man experiment directly measured food eaten during a controlled meal. Its strongest conclusion concerns acute intake under those conditions. The later three-visit study included lean and obese participants and again found increased intake. This extends the population studied, while retaining a short laboratory time window. Neither paper follows the adaptive changes in intake, expenditure and behaviour that determine longer-term body weight. [1] [2]

How to read the meal-study design

The expanded experiment used randomised, double-blind comparisons, a fixed breakfast and a subsequent buffet. Those controls help attribute differences in that meal to the intervention rather than obvious differences in meal availability. They do not make the buffet a measure of sustained nutrition or patient benefit. The observation that fullness afterwards was similar also cautions against translating one appetite rating into a general account of eating behaviour. The relevant endpoint here is greater food intake, not fat loss or improved muscle function. [2]

Limitations & uncertainties

  • The small male sample limits generalisability.
  • A single meal does not show a sustained change in weight, body composition or performance. Supplied-product identity and quality remain separate questions.

Open research questions

  • Would a follow-up study measure sustained intake, energy expenditure, body composition or functional outcomes?
  • Does the intended model match the population and exposure in the cited experiment?

Selected papers & source records

Download bibliography
Human studyNamed compoundAbstract / record checked

1. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men (opens in a new tab)

Laferrère B, Abraham C, Russell CD, Bowers CY. (2005). Journal of Clinical Endocrinology & Metabolism. DOI: 10.1210/jc.2004-1719 (opens in a new tab) · PMID 15699539

Design & population
Acute controlled experiment comparing GHRP-2 with saline in seven lean healthy men, followed by a buffet meal.
What the study found
Participants consumed more food during GHRP-2 exposure, and circulating GH increased.
Limits on interpretation
Seven participants and a single meal cannot establish sustained weight change, muscle growth or long-term safety.
Human studyNamed compoundAbstract / record checked

2. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake (opens in a new tab)

Laferrère B, Hart AB, Bowers CY. (2006). Obesity. DOI: 10.1038/oby.2006.121 (opens in a new tab) · PMID 16861611

Design & population
Double-blind randomized three-visit experiment in 19 healthy weight-stable participants, including 10 lean and 9 obese people; GHRP-2 exposures were compared with placebo.
What the study found
Food intake increased with GHRP-2 exposure in both lean and obese participants. Greater appetite before the meal did not translate into greater fullness afterwards.
Limits on interpretation
Acute controlled-meal research. It does not establish long-term energy balance, sustained weight change or an obesity treatment.

Search & review scope

Targeted web searches of PubMed-indexed primary research and original journal records. Selected abstracts and citation metadata were checked; full-text sections were consulted for the records explicitly labelled full-text. Retrieved records and targeted notice searches were also checked for visible corrections or retractions.. Checked 9 November 2026.

Selected primary research relevant to the named compound, its molecular specification and the endpoints described below.

Narrative selection, not a systematic review, comprehensive safety assessment or complete retraction audit. PubMed/PMC full-text access was intermittent. An abstract or selected-section review cannot replace appraisal of the complete methods, supplements and underlying data. Absence from this selection does not establish absence of research.

Recorded search terms
  • site.pubmed.ncbi.nlm.nih.gov/15699539/ (direct record check)
  • site.pubmed.ncbi.nlm.nih.gov GHRP-2 chronic infusion food intake human randomized
  • "Obese Subjects Respond" "GHRP-2" Laferrere DOI

Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.

Cite this review

HeartPep. GHRP-2: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/ghrp-2.

HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

← All reviews and reference notes